March 8, 2024 | Leadership, Women in healthcare, oncology
Women, Power, and Cancer: a Lancet commission, studied the interaction of women and cancer through a social justice and equity lens. What does ‘power’ mean when it comes to cancer care?

“The origins of our commission, Women, Power, and Cancer, date back to a 3-part series of articles in the Lancet called Health, Equity, and Women’s Cancers that I was privileged to have led,” says Dr. Ophira Ginsburg, Senior Advisor for Clinical Research at the National Cancer Institute Center for Global Health, National Institutes of Health.
For the series, 40 people from 18 countries came together to focus on breast and cervical cancer—diseases that we have adequate knowledge about how to prevent, control, and in many cases cure, Ginsburg says. And yet there were huge national and, more importantly, global health disparities with these two cancers in terms of women accessing essential information.
The articles, published online in 2016, drew attention to the social issues that prevent women from accessing care in different settings.
Several years later, The Lancet’s editor in chief asked Ginsburg if she thought enough progress had been made around women accessing vital healthcare. “Of course, the answer was no!” Ginsburg says. That led to the idea for a broader study, not just around cervical and breast cancer but across the cancer continuum, in terms of women understanding their risks; having the agency, the right, and the opportunity to prevent cancer from occurring in the first place; and being able to seek and obtain quality, respectful care.
As you’ll hear in this insightful episode, the commission studied the interaction of women and cancer “through a social justice and equity lens” to highlight the global inequities that women face with respect to cancer care and control.
The “power” in the title refers to control in 3 domains: decision-making, knowledge, and economics, Ginsburg says. She, co-chair Verna Vanderpuye, and the other commissioners were stunned to find that cancer ranks in the top 3 causes of premature mortality among women in almost all countries worldwide. They found that of the 2.3 million women who died prematurely from cancer in 2020, 1.5 million such deaths could have been prevented if every woman had access to what we already know regarding primary prevention and early detection.
In 2020 alone, 1 million children lost their mothers to cancer. “And that number obviously is horrifying,” Ginsburg says.
Listeners of this episode will learn the 10 priority actions the committee identified for moving forward. “That may sound like a lot,” Vanderpuye says, “but the scope of the problem is so huge it’s the only way to make sure we can leverage our findings with what should happen in real life.”
Vanderpuye, senior consultant at the National Center for Radiotherapy Oncology and Nuclear Medicine in Accra, Ghana, and adjunct professor in the Department of Oncology at Queens University in Kingston, Canada, also touches on a theme that surfaces throughout all the conversations with women leaders in healthcare: “We need more women CEOs of hospitals all the way down to medical schools, to deans, to leaders in medical oncology, boards in oncology, societies, academic research.” Fewer women in leadership roles, she says, means funding and women-specific healthcare needs and issues get overshadowed.
Listen now to season 2, episode 2 on Medscape, Spotify or Apple.
Follow us on LinkedIn for updates on upcoming podcasts and more eye-opening conversations.
For more information, please contact Jelena Spyropoulos (Global) or Piyali Shin (US).
About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...
Highlights from the Medscape Education full panel discussion during this year's #ESMO22.
On 11th September, the Medscape team came together at the Eiffel Tower for an exciting event attended by expert faculty, patient advocates and more than a hundred supporters of our...
This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...
This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...
This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...
